PROMETHAZINE HYDROCHLORIDE MARKET

INTRODUCTION TOPROMETHAZINE HYDROCHLORIDE MARKET

The drug promethazine hydrochloride is a member of the phenothiazines drug class. Its primary function is that of an antihistamine, which means that it relieves allergy-related symptoms like itchiness, sneezing, and runny nose. It also has sedative qualities and is occasionally employed to relieve nausea and vomiting.The way that promethazine functions is by blocking the effects of histamine, a chemical that the body naturally produces.

The way that promethazine hydrochloride works is by inhibiting the effects of histamine, a substance that the body releases in response to allergens and is responsible for symptoms like swelling and itching. Promethazine hydrochloride can help lessen or get rid of these symptoms by inhibiting histamine.

It is often consumed orally and is available in a number of forms, including pills, capsules, suppositories, and syrups. To treat itching, it can also be injected or applied topically.

Promethazine hydrochloride can make you drowsy and make it difficult for you to do duties that call for attentiveness, such driving or operating machinery. As a result, it is advised that you refrain from doing so while taking this drug. Promethazine hydrochloride should also not be administered to children under the age of two since it may seriously impair their ability to breathe.

PROMETHAZINE HYDROCHLORIDE MARKET SIZE AND FORECAST

Global Promethazine Hydrochloride market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

PROMETHAZINE HYDROCHLORIDE MARKETNEW PRODUCT LAUNCH

Promethazine Hydrochloride and Phenylephrine Hydrochloride Syrup (Promethazine/Phenylephrine) and Promethazine Hydrochloride, Phenylephrine are two more promethazine syrup formulations that Akorn, Inc. has released.

The existing Promethazine formulations from Akorn, such as Promethazine HCl Oral Solution, USP, Promethazine HCl and Codeine Phosphate Syrup CV, and Promethazine HCl and Dextromethorphan HCl Oral Solution, are supplemented by these two new products.

The U.S. Food and Drug Administration (FDA) gave its final approval to Mylan Pharmaceuticals Inc.'s Abbreviated New Drug Application (ANDA) for Promethazine Hydrochloride (HCl) Tablets, USP, 12.5 mg, 25 mg, and 50 mg. The symptoms of some allergic reactions, such as perennial and seasonal allergic rhinitis, are treated with promethazine HCl tablets.

PROMETHAZINE HYDROCHLORIDE MARKETCOMPANY PROFILE

• Sun Pharmaceutical Industries
• Hikma Pharmaceuticals
• Wockhardt Ltd
• Teva Pharmaceuticals
• Zydus Cadila Healthcare

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS OFPROMETHAZINE HYDROCHLORIDE MARKET

1. How many Promethazine Hydrochloride are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Promethazine Hydrochloride and key vendor selection criteria
3. Where is the Promethazine Hydrochloride manufactured? What is the average margin per unit?
4. Market share of Global Promethazine Hydrochloride market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Promethazine Hydrochloride in-house
6. key predictions for next 5 years in Global Promethazine Hydrochloride market
7. Average B-2-B Promethazine Hydrochloride market price in all segments
8. Latest trends in Promethazine Hydrochloride market, by every market segment
9. The market size (both volume and value) of the Promethazine Hydrochloride market in 2024-2030 and every year in between?
10. Production breakup of Promethazine Hydrochloride market, by suppliers and their OEM relationship